View this video to learn more about BreastDefense
BreastDefense is a molecular screening test that is aiming for 99% accuracy in the detection of all major invasive breast cancers - at any stage from 1 through 4.
About 1 woman in 8 in the U.S. will develop invasive breast cancer during her lifetime. It is estimated that 260,120 women in 2018 will be diagnosed. Invasive breast cancers are dangerous.
Women need an accurate screen and survivors want to monitor themselves. BreastDefense, an easy and accurate blood test will put fear at bay. It will eliminate the need for inaccurate tests that can do more harm than good.
Contact Peter Blaney at firstname.lastname@example.org
SignPost has already raised $1.1M to complete the first development trial of BreastDefense.
Today Induran is raising additonal funds to complete validation studies.
We are 99% confident that the validation studies will succeed and BreastDefense can begin saving lives.
Copyright © 2018 Induran Ventures Inc. - All Rights Reserved.